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Progressive muscle relaxation reduces
migraine frequency and normalizes
amplitudes of contingent negative
variation (CNV)
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Abstract
Background: Central information processing, visible in evoked potentials like the contingent negative variation
(CNV) is altered in migraine patients who exhibit higher CNV amplitudes and a reduced habituation. Both
characteristics were shown to be normalized under different prophylactic migraine treatment options whereas
Progressive Muscle Relaxation (PMR) has not yet been examined. We investigated the effect of PMR on clinical
course and CNV in migraineurs in a quasi-randomized, controlled trial.
Methods: Thirty-five migraine patients and 46 healthy controls were examined. Sixteen migraineurs and 21 healthy
participants conducted a 6-week PMR-training with CNV-measures before and after as well as three months after
PMR-training completion. The remaining participants served as controls. The clinical course was analyzed with
two-way analyses of variance (ANOVA) with repeated measures. Pre-treatment CNV differences between migraine
patients and healthy controls were examined with t-tests for independent measures. The course of the CNV-parameters
was examined with three-way ANOVAs with repeated measures.
Results: After PMR-training, migraine patients showed a significant reduction of migraine frequency. Preliminary to the
PMR-training, migraine patients exhibited higher amplitudes in the early component of the CNV (iCNV) and the overall
CNV (oCNV) than healthy controls, but no differences regarding habituation. After completion of the PMR-training,
migraineurs showed a normalization of the iCNV amplitude, but neither of the oCNV nor of the habituation coefficient.
Conclusions: The results confirm clinical efficacy of PMR for migraine prophylaxis. The pre-treatment measure confirms
altered cortical information processing in migraine patients. Regarding the changes in the iCNV after PMR-training,
central nervous mechanisms of the PMR-effect are supposed which may be mediated by the serotonin metabolism.
Keywords: Migraine, Contingent negative variation, Progressive muscle relaxation, Cortical preactivation, Migraine
prophylaxis
Background
Migraine is one of the most frequent neurological diseases,
generated by an interplay of neurological, physiological and
psychological factors [1, 2]. It is generally accepted that mi-
graine involves a disturbance of information processing,
probably caused by an altered cortical preactivation level
[3–5]. One method for examining cortical information
processing is the application of event-related potentials,
for example the “Contingent Negative Variation” (CNV)
[6]. The CNV is a slow cortical event-related potential
which develops between two related stimuli. The first
serves as a warning stimulus (S1), the second (S2) as an
imperative stimulus requiring a motor answer by the sub-
ject. The psychological concepts associated with the CNV
are motivation, preparation, and attention [7, 8]. Several
components can be distinguished: 1) the overall CNV
(oCNV), which is the mean amplitude between S1 and S2;
2) the initial CNV (iCNV), which occurs in an interval of
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200 ms around the individual amplitude maximum during
550–750 ms after S1; 3) the terminal CNV (tCNV),
measured as mean amplitude within the last 200 ms
before onset of S2 and finally 4) the habituation coefficient
determined by examining the CNV amplitude during
the course of a measure with decreasing amplitudes
interpreted as habituation and increasing amplitudes
interpreted as lack of habituation [7]. Migraine patients
exhibit higher CNV amplitudes, especially of the iCNV
and the oCNV, as well as a reduced habituation behavior
within the interictal interval, which points to a cortical
dysbalance [3, 5, 9]. Applying prophylactic treatments,
such as betablockers, antiepileptics and even non-
pharmacological treatment options like behavioral therapy
or physical exercise, CNV parameters tend to normalize.
This was interpreted as a possible equalization of the cor-
tical dysbalance [10–13]. Within the non-pharmacological
prophylactic treatment options, progressive muscle relax-
ation (PMR) has not yet been examined in this aspect.
PMR is a systematic relaxation technique developed by
Edmund Jacobson [14] and is routinely used in migraine
attack prevention [15]. The two main principles of this
technique are the incompatibility of tension and relaxation
and the interaction of muscular and mental levels [16].
PMR has been shown to be potent in the prevention of
migraine attacks [17–21]; its effectiveness is comparable
to pharmacological migraine prophylaxis [22, 23]. Thus,
Grade A was given to PMR by the United States Headache
Consortium [24]. However, most of the studies suffer from
different deficits. For the most part, they were conducted
before introduction of IHS criteria ensuring exact diag-
nosis. There was often no accurate description of the
relaxation technique taught to the participants. In some
studies, PMR was taught within one or two sessions
[19, 20, 25], which is insufficient according to the rec-
ommendations of Bernstein and Borkovec [16]. Thus,
in contrast to the persuasion of a high effectiveness for
PMR in migraine treatment, the empirical basis is not
as solid as expected. Furthermore, little is known about
the mechanisms behind the effect evoked by PMR. It
was mainly explained by a possible reduction of the
autonomic arousal or an enhancement of self-efficacy.
For migraine patients, no effects on the cortical level
were examined until now. This is surprising regarding
the effects of other prophylactic treatment options on
CNV-parameters.
Overlooking previous findings concerning CNV and
PMR in the context of migraine, the following questions
are intended to be answered:
 Can a clinical improvement be achieved by
application of PMR?
 As a basis for potential effects of PMR on CNV
parameters: can we replicate known differences in
the amplitudes of the iCNV, the oCNV, and the
habituation coefficient between migraine patients
and healthy controls?
 Does PMR have an effect on iCNV amplitude,
oCNV amplitude and habituation coefficient?
Methods
The study conformed to the Declaration of Helsinki and
was approved by the Ethics committee of the University
Medicine Rostock (ID: A 2011 29).
Overall, four groups were compared: migraine patients
and healthy controls with one subgroup each conducting
a PMR-training and the remaining participants staying
on the waiting-list. Measurements took place before
and after the PMR-training as well as 3 months after
completion.
Sample size was calculated using the following formula
for ANOVA with repeated measures [26] resulting in 21
participants per group and therefore 84 participants
altogether.












n, number of participants; λ, noncentral parameter defin-
ing skewness and kurtosis of the alternative hypothesis
distribution; α = 0.05; β = 0.80; Ω2, effect size; r, correlation
between measures; p, number of repeated measures.
To face possible drop out of participants, 52 migraine
patients and 50 healthy controls were recruited from
September 2012 to November 2013 by newspaper an-
nouncements, flyers stored in general medical practices
and a newsletter sent to the staff of the University
Medicine Rostock. After being informed and examined
with structured interviews by neurologists or pain spe-
cialists, participants gave informed consent and were
quasi-randomly assigned to either an intervention or a
waiting-list group. Participants of the waiting-list group
were offered to take part in PMR-training after completion
of the study. Inclusion criteria were age between 18 and
65 years, absence of chronic somatic or psychiatric diseases
(other than migraine in the case of migraine patients) and
for migraine patients duration of disease at least 1 year, less
than 15 days with migraine per month, less than 10 days
with acute medication, no prophylactic treatment during
the 3 months before onset of the study. Exclusion criteria
were pregnancy or use of drugs. In the course of the study,
7 migraine patients and 4 healthy persons dropped out
(largely because of lack of time) and were excluded from
analysis; another 10 migraineurs were excluded from ana-
lysis because of a migraine attack within 3 days after the
CNV-measure. This high rate of excluded patients was
unexpected but necessary to insure interpretability of
the results regarding the periodicity of the CNV [27].
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Neither the dropped out participants nor the excluded
patients differed in the pre-intervention measures from
the participants who completed the study with the excep-
tion of migraine frequency: participants who dropped out
showed significantly fewer migraine days and migraine
attacks per month.
Overall, four different subject groups were examined
in this study. The first (n = 16) and the second group
(n = 19) consisted of migraine patients with and with-
out aura, diagnosed according to the IHS-criteria [28].
The third (n = 21) and the fourth group (n = 25) consisted
of healthy controls without migraine in the personal or
family history. All participants were aged between 18 and
63 years. Table 1 shows demographic and clinical charac-
teristics of the sample.
One migraine group (group 1, n = 16) and one healthy
control group (group 3, n = 21) conducted a PMR-training
program consisting of six weekly sessions. Participants
who conducted the PMR-training underwent a CNV-
examination before and after the training as well as 3
months after completion. Subjects in the waiting-list
groups underwent three CNV-measures at intervals of
4 weeks. Because of the periodicity of the CNV [27],
the recordings took place at least 3 days before or after
a migraine attack, verified by telephone call after the
recording session. All migraine patients kept headache
diaries during the course of the study in order to register
migraine frequency. Figure 1 gives an overview of the
course of the study.
CNV-recordings
CNV-recordings took place at similar times of day for
each subject. The participants were seated in a relaxed
position and instructed to focus on a designated spot on
the wall to avoid eye movement artifacts. The CNV-
measure comprised 32 Go-trials consisting of an acous-
tic warning stimulus (S1; 1000 Hz, duration 100 ms) and
an acoustic imperative stimulus (S2; 2500 Hz, maximum
duration 1000 ms). Subjects were asked to press a button
immediately after onset of S2, which instantly interrupted
the tone. Recordings of each trial started 1000 ms before
onset of S1. This period was used for a baseline measure-
ment. The interval between S1 and S2 (interstimulus
interval, ISI) was 3000 ms and the recordings ended
1000 ms after S2. Thus, each trial had a duration of
5000 ms. The interval between two trials (intertrial
interval, ITI) was randomized between 6 and 10 s.
Additionally to these Go-trials, 8 randomly presented
NoGo-trials, consisting of a 200 Hz-tone without any
answer requested by the subject were added to keep
participants in an attentive state [9]. These trials were
not analyzed.
The CNV was recorded over Cz according to the
international 10-20-System with Ag/AgCl ring electrodes.
Linked mastoids were used; the impedances were kept
below 10 kOhm. Eye movements were controlled by an
electrooculogramm (EOG) with an electrode placed 2 cm
below the left eye.
Stimuli presentation was controlled by the program
E-Prime, CNV-recording was done with Brain Vision
Recorder 1.20 and data analysis was implemented with
Brain Vision Analyzer 1.05.
CNV analysis
The overall CNV (oCNV) was calculated as the mean
amplitude between S1 and S2. For iCNV amplitude, the
individual amplitude maximum in the interval between
550 and 750 ms after S1 was determined according to
Böcker et al. [7]. The mean amplitude in the window of
200 ms around this maximum was defined as the iCNV.
The tCNV was defined as mean amplitude in the 200 ms
before onset of S2. Additionally, the habituation coefficient
was calculated by assigning the Go-trials to 8 blocks and
calculating the average amplitude for each block. Using
regression analysis, the individual course of the CNV was
determined with a positive slope indicating habituation
behavior and a negative slope indicating lack of habitu-
ation. Data acquisition was conducted unblinded, data
analysis was blinded.










n 16 19 21 25
Age (years) 36.4 33.8 37 37,2 0.79 (n.s.)
Male (%) 3 (18.8) 1 (5.3) 5 (23.8) 7 (28) 0.28 (n.s.)
Female (%) 13 (81.2) 18 (94.7) 16 (76.2) 18 (72) 0.28 (n.s.)
Duration of disease (months) 136.5 135.7 – – 0.98 (n.s.)
Type of migraine (MO/MA) 10/6 14/5 – – 0.36 (n.s.)
Monthly migraine attacks/days
with migraine
3.81/5.5 3.47/5.79 – – 0.56 (n.s.)/0.74 (n.s.)
MO migraine without aura, MA migraine with aura, sign. significance, n.s. not significant
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With regard to previous studies, only results concerning
iCNV, oCNV, and habituation of the iCNV are presented.
PMR training program
According to Bernstein and Borkovec [16], the PMR-
training program included 16 muscle groups that were
slightly tensed and thereafter relaxed. Participants were
told to focus on the sensations of tension and relaxation
and the difference between these two states which re-
sults in a deep state of relaxation. They were taught the
long PMR-version, followed by successive reductions of
the sequences with 7 and 4 muscle groups in the second
and third session, respectively. The fourth session in-
volved an envision exercise without muscle tension. The
5th and the 6th sessions comprised conditioned and dif-
ferential relaxation. Training sessions were conducted in
groups of 8 to 10 participants (migraineurs and healthy
controls conjoined).
Statistical analysis
Statistical analyses were conducted using SPSS 21 (Stat-
istical Package of Social Sciences). For clinical data we
performed a two-way ANOVA (analysis of variance)
with repeated measures to examine the influence of the
between-group-factor intervention (PMR vs. waiting-list)
on migraine frequency. T-tests were performed to find
possible differences in the amplitude of the iCNV, the
oCNV, and the habituation coefficient between migraine
patients and healthy controls in the pre-measure. Lastly,
a three-way ANOVA with repeated measures with the
between-group-factors diagnosis (migraine vs. healthy)
and intervention was conducted to detect possible changes
within the different CNV-components after completion of
a PMR-training. For most of the outcome variables the
ANOVA requirements of normal distribution, homogenous
variances and homogeneous correlations were fulfilled.
There were only slight violations for a small number of var-
iables which could be tolerated given the robustness of the
ANOVA against these deviations. The significance level
was kept at 0.05 with two-tailed testing.
Results
Clinical data
Two-way ANOVA with repeated measures revealed sig-
nificant interactions for time x intervention for both the
number of migraine attacks per month (Ftime*PMR = 4.62;
p = 0.017) and migraine days (Ftime*PMR = 3.39; p = 0.046),
which corresponds to a significant reduction of migraine
attacks and days with migraine per month in the group
of patients with PMR-training compared to those from
the waiting-list. Additionally, a significant time-effect oc-
curred both for migraine attacks (Ftime = 4.46; p = 0.02)
and days with migraine (Ftime = 8.59, p = 0.001).
Table 2 displays descriptive data for migraine fre-
quency at all measures; Fig. 2 shows migraine frequency
in the study course for both groups.
Fig. 1 Process of the study for the different groups
Table 2 Migraine frequency of both migraine groups for all measurement points
n Number of migraine attacks Number of days with migraine
M SD M SD
1 (pre) PMR 16 3.81 1.8 5.5 2.77
Waiting-list 19 3.47 1.61 5.79 2.3
2 (post) PMR 16 2.88 1.41 3.88 2.28
Waiting-list 19 3.32 1.77 5.53 3.1
3 (follow-up) PMR 16 2.25 1.34 3.13 1.93
Waiting-list 19 3.53 1.98 5.26 2.2
n number of patients, M mean value, SD standard deviation
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The decline in migraine frequency corresponds to a
reduction of 24 and 41 % for number of migraine attacks
from the first to the second and the third recording, re-
spectively. For number of days with migraine, this repre-
sents a reduction of 29 and 43 %, respectively.
CNV-data: comparison of migraine patients and healthy
controls
Migraine patients exhibited significantly higher iCNV-
amplitudes (t = −2.63; p = 0.006) and oCNV-amplitudes
(t = −3.39; p < 0.001) compared to controls in the first
measure. There were no statistical differences regarding the
habituation coefficient (t = −0.72; p = 0.22). Pre-treatment
CNV data are presented in Table 3; Fig. 3 shows CNV
Grand Averages for migraine patients and healthy controls.
Longitudinal CNV-data: effect of PMR-training on CNV
parameters
ANOVA revealed significant main effects of time (F = 3.72;
p = 0.029) and diagnosis (F = 5.53; p = 0.023) for iCNV am-
plitudes which represents significantly higher amplitudes
for migraine patients compared to controls and a significant
change in the course of the study across all groups. Still, a
significant interaction effect time x diagnosis x intervention
(F= 3.39; p = 0.039) was found which points to relevant re-
ductions of the iCNV amplitude in the migraine interven-
tion group. With the object of testing for a normalization
of this CNV component, groups 1 (migraine PMR) and 4
(healthy waiting-list; representing normal population) were
compared at post and follow-up measurement points.
There were no significant differences between these groups
at measure 2 (t = −0.63; p = 0.53) nor measure 3 (t = −0.73;
p = 0.47), representing a normalization of the iCNV.
For the amplitudes of the oCNV, ANOVA revealed
significant main effects of time (F = 11.96; p < 0.001) and
of diagnosis (F = 6.06; p = 0.016) showing overall higher
oCNV amplitudes for migraine patients compared to
healthy participants and a decline of amplitudes across
all groups in the course of the study.
For the habituation coefficient there were no main
or interaction effects. For a better understanding of
this unexpected finding, correlation analyses for the
non-intervention groups (groups 2 and 4; migraine
waiting-list and healthy waiting-list) over the different
measurement points were conducted to estimate the
stability of the habituation coefficient across repeated
measurements. Although no changes were anticipated in
these groups, the analysis revealed correlation coefficients
close to zero (rpre/post = −0.004, p = 0.98; rpre/follow-up = 0.14,
p = 0.38; rpost/follow-up = 0.004, p = 0.98).
Table 4 lists descriptive data for the CNV-components
for all groups and all measures; Fig. 4 shows CNV parame-
ters in the course of the study for all groups. Figure 5
shows CNV Grand Averages for migraine PMR group and
healthy waiting-list group at the pre, post and follow-up
measure pointing to approximating CNV curves and thus
normalization of the CNV in the migraine PMR group.
Discussion
Clinical efficacy of a six-week PMR-training
Our study confirmed that PMR exhibits a substantial
effect on migraine reduction. After a 6-week treatment













number of migraine attacks number of days with migraine
a b
Fig. 2 Migraine frequency for both migraine groups in the course of the study for a number of migraine attacks and b days with migraine
Table 3 Pre-treatment CNV data for migraine patients vs. healthy controls
M migraine patients (n = 35) (SD) M healthy controls (n = 46) (SD) t-value (p)
iCNV amplitude (μV) −11.65 (5.65) −8.62 (4.37) −2.63 (0.006**)
oCNV amplitude (μV) −8.66 (2.65) −6.7 (2.51) −3.39 (<0.001***)
Habituation coefficient −0.05 (1.08) 0.13 (1.11) −0.72 (0.22)
μV microvolt, M mean value, n number of persons, SD standard deviation; **p <0.01, ***p <0.001
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and Borkovec [16], migraine frequency decreased signifi-
cantly. The significant interaction terms of time and inter-
vention for both migraine attacks and days with migraine
demonstrate that migraine patients benefit from a regular
PMR-training having a lower migraine frequency compared
to those without relaxation treatment.
Thus, we could show a specific migraine-reducing ef-
fect due to the elaborate acquisition of PMR relaxation
technique which could not be inferred in such a distinct
way from previous studies [17–21]. As shown in other
studies, migraine frequency even decreased after com-
pletion of the treatment [23]. PMR was suggested to
operate by enhancing self-efficacy [23]. With every
successful relaxation exercise migraine patients may
develop growing confidence in their own coping abilities.
It can be expected that for migraineurs, the feeling of be-
ing able to control one’s own relaxation state is helpful in
dealing with the disease and reinforces control expectancy.
Actually, there is growing interest in the role of expect-
ancy in the context of migraine treatment. Recent findings
showed the meaning of patients’ expectations for the
amount of treatment efficacy [29]. Thus, these expectations
should be taken into account in the context of behavioral
migraine prophylaxis.
CNV data: differences between migraine patients and
healthy controls in the CNV parameters
As expected, migraine patients exhibited significantly
higher amplitudes in the iCNV and oCNV pre-treatment
measure which is in line with other studies (e.g. [9]).
These findings were mainly interpreted to be caused by
a lower cortical preactivation level and to concern atten-
tion allocation [5, 9]. From a theoretical point of view,
one explanation was seen in the ceiling theory [30, 31]
Fig. 3 CNV Grand Averages for migraine patients (red) and healthy controls (black)
Table 4 CNV data for all groups at pre, post and follow-up measurement
Pre-treatment amplitude in μV
(SD)
Post-treatment amplitude in μV
(SD)
Follow-up amplitude in μV
(SD)
iCNV Migraine + PMR −11.46 (4.79) −8.68 (3.54) −8.5 (4.88)
− PMR −11.81 (6.4) −11.22 (4.85) −11.19 (5.1)
Healthy + PMR −8.19 (3.25) −8.66 (4.35) −8.72 (3.58)
− PMR −8.97 (5.18) −7.76 (5.13) −7.24 (5.64)
oCNV Migraine + PMR −8.58 (2.26) −6.59 (1.93) −6.28 (2.41)
− PMR −8.72 (3) −7.08 (2.07) −6.71 (2.55)
Healthy + PMR −6.3 (2.23) −5.61 (4) −6.3 (2.57)
− PMR −7.04 (2.73) −5.6 (2.74) −5.72 (3.72)
Habituation coefficient Migraine + PMR 0.20 (1.28) −0.31 (0.94) 0.31 (0.58)
− PMR −0.26 (0.87) −0.18 (0.93) 0.10 (0.87)
Healthy + PMR −0.03 (1.23) 0.21 (0.85) 0.08 (0.81)
− PMR 0.26 (1.01) −0.01 (0.83) −0.14 (0.82)
μV microvolt, SD standard deviation
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which assumes that for evoked potentials, cortical re-
activity is reduced after having reached a ceiling point
which initiates a habituation response. According to the
ceiling theory, a lower preactivation level in migraine pa-
tients would cause a delayed or missing habituation be-
cause the ceiling would be reached later than in healthy
people. In this context, overall higher amplitudes of
evoked potentials in migraine patients are seen as a con-
sequence of the missing or reduced habituation.
Unexpectedly, we did not find significant differences
in the habituation behavior between migraine patients
and controls although this seems to be a quite robust
finding in other studies for different modalities [9, 32].
As the mean values for migraine patients and for healthy
controls present the expected (albeit not significant)
differences with migraineurs showing a negative habitu-
ation coefficient (habituation deficit) and controls a posi-
tive habituation coefficient (habituation), this has to be
ascribed to the low number of participants and thus the
low power. Still, not all studies could show a CNV habitu-
ation deficit of migraine patients in the past. Mulder et al.
found similar habituation processes in migraineurs and
healthy controls; but a number of methodological and
recruitment-associated reasons limit the comparability to
our results [33]. In VEP studies, Omland et al. [34] could
not observe any lack of habituation in migraine patients
which they supposed to be largely an effect of blindedness;
past trials with findings of habituation deficits have not
been blinded. However, especially in the CNV, there may
be many alternative, possibly more important factors than
Fig. 4 CNV-parameters for all groups in the course of the study for a iCNV amplitude, b oCNV amplitude and c habituation coefficient
Fig. 5 CNV Grand Averages for migraine PMR patients and healthy controls without PMR-training. Migraine PMR patients are displayed in red,
healthy controls without PMR are displayed in black a before b after and c 3 months after completion of the PMR-training
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blindedness, which influence habituation behavior [35].
Restrictedly, the small sample size of the current study
doesn’t offer any further analysis of this point.
Even if our data do not confirm all presumptions of
the ceiling theory, we found and altered information
processing which presumably can be explained by an
altered preactivation level.
Longitudinal CNV data: effect of PMR-training on CNV
parameters
For iCNV amplitude, ANOVA revealed a significant
interaction of time, diagnosis and intervention which in-
dicates that the greatest changes of iCNV amplitudes ap-
pear within the migraine PMR group. A t-test of mean
differences for migraine patients with PMR and healthy
controls without PMR who are supposed to represent
normal population revealed no significant iCNV differ-
ences, neither at measure 2 nor at measure 3. This result
points to a normalization of iCNV amplitudes. For oCNV
amplitudes, we found significant main effects of time and
diagnosis illustrating an overall higher negativity of oCNV
amplitudes in migraine patients irrespective of the inter-
vention. The main effect of time represents considerable
changes of the oCNV in all groups. For the habituation
coefficient no main or interaction effects could be found.
Additionally, there were no correlations between the dif-
ferent measurements for the non-intervention groups.
The longitudinal findings are partly in line with an
amount of other studies. For the iCNV amplitude, we
could show a normalization as it was seen after applica-
tion of other prophylactic treatment options [10–13].
This is interpreted as an effect of PMR on the cortical
level. A mediating factor may be the neurotransmitter
serotonin which was shown to be reduced in migraine
patients in the interictal interval [36]. Also, serotonin is
known to influence the preactivation level [36]; so a dys-
regulation of the serotonin level is expected to cause a
dysbalance of the cortical preactivation level. However,
there are no studies examining the effect of relaxation
techniques on the serotonin level, so a missing link per-
sists. At least one review indicates an effect of relaxing
massages on serotonin metabolism [37], leading to the
hypothesis that PMR-training may exhibit cortical effects
by balancing the serotonin metabolism. In this sense, a
subsequently more balanced preactivation level may help
to prevent migraine attacks.
For the amplitude of the oCNV, no PMR-specific changes
were found. The main effect of time in the absence of any
interaction effect demonstrates an overall decline of the
amplitudes in the course of the study whereat migraine
patients exhibited higher amplitudes at any measure
(main effect of diagnosis). Thus, the oCNV seems to be
unaffected by PMR but to systematically decline in repeated
measures. One possible explanation could be the existence
of long-term habituation processes [38], a phenomenon
which is not well examined so far and has to be interpreted
with caution.
A striking result of the current study is the absence of
main or interaction effects concerning the habituation
coefficient which is in opposition to other studies that
found the habituation coefficient to be influenced by
prophylactic treatment [11–13]. Since in most studies
the same methods of data acquisition and analysis were
used, no methodological differences could explain the
discrepancy. Presumably, the differences can at least
partly be explained by the low number of participants.
The aspired sample size could not be reached which re-
sults in low power. This difficulty is aggravated by the
high variability of the habituation coefficient, visible for
example in the high standard deviation in the first meas-
ure of the migraine PMR group. However, in our study,
habituation behavior all in all was found highly variable
as can be seen in low correlations across the repeated
measurements for the non-intervention groups. Actually,
there is no study examining the reliability of the habituation
coefficient of the CNV. Instead, some authors already em-
phasized the high variability of evoked potentials and their
sub-components in migraine patients [34, 39]; others found
low reliability values in VEPs and emphasized the necessity
of (large) group analyses to interpret habituation indexes
[40]. Thus, habituation behavior may be a variable dimen-
sion with a high sensitivity to constantly changing external
(e.g. noise, odor) or internal (e.g. motivation, tiredness)
factors that could not sufficiently be controlled for in
our study due to the small sample size.
Study limitations of the current investigation are pri-
marily the low number of participants due to the period-
icity of the CNV and the resulting exclusion of several
measures. The aspired number of participants could not
be reached which is supposed to have contributed to the
unexpected results concerning the habituation coeffi-
cient. Furthermore, the differing participant recruitment
mode with patients not being recruited from specialized
headache ambulances, but from general population, po-
tentially limits the comparability to other investigations.
However, this presumably enhances the generalizability
of our findings to normal migraine population [40]. In
future studies, more participants should be included,
possibly with a multicenter approach. A longer follow-
up period may be favorable to examine the stability of
the effects found.
Conlusions
In summary, this study shows a clinical effect of regular
PMR application on migraine frequency. Additionally, a
normalization of the iCNV in migraine patients after
PMR-training indicates that PMR is operating not only
on the psychological, but also on the electrophysiological
Meyer et al. The Journal of Headache and Pain  (2016) 17:37 Page 8 of 9
level. A clinical implication of the results may be that
patients are given a more detailed explanation of the ef-
fects of PMR on the electrophysiological level, which
might fill a perceived gap between a somatic disorder
and a behavioral intervention.
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